Our Firm is representing federal testosterone lawsuit plaintiffs, and we anticipate that next month’s conference will provide new information regarding the status of discovery, bellwether case selection, and other matters relevant to these cases.
New York, New York (PRWEB) June 07, 2015
Hundreds of federally-filed testosterone treatment lawsuits (http://www.testosteronelawsuithub.com/) continue to move forward in the multidistrict litigation currently underway in U.S. District Court, Northern District of Illinois. According to court documents, the litigation’s next monthly Case Management Conference has been scheduled, and will take place on July 21, 2015 at 11:00 a.m. (In re: Testosterone Replacement Therapy Product Liability Litigation - MDL No. 2545)
“Our Firm is representing federal testosterone lawsuit plaintiffs, and we anticipate that next month’s conference will provide new information regarding the status of discovery, bellwether case selection, and other matters relevant to these cases. We look forward to providing our clients with an update regarding the progress of this litigation,” says Sandy A. Liebhard, a partner at Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm continues to offer free case reviews to men who may have been harmed by low testosterone therapy medications.
Court filings indicate that more than 1,500 testosterone lawsuits are pending in the Northern District of Illinois, all of which allege that the use of prescription low testosterone therapy is associated with an increased risk of heart attack, stroke and other life-threatening cardiovascular complications. Among other things, plaintiffs claim that the drug’s manufacturers induced many men to use prescription testosterone treatments in the absence of a true medical need by engaging in deceptive advertising that positioned their products as safe and effective remedies for low libido, weight gain, loss of muscle mass, fatigue and other symptoms associated with age-related drops in testosterone. The lawsuits point out that the drugs have only been approved to treat men who suffer from hypogonadism, or low testosterone that is the result of an underlying injury or medical condition.
According to court documents, the lawsuits note that the U.S. Food & Drug Administration’s (FDA) launched a review of the cardiovascular risks potentially associated prescription testosterone products in January 2014.* The results of that review were announced by the FDA on March 3, 2015, at which time the agency ordered the manufacturers of prescription testosterone treatments to modify their labels with information regarding a potential association with an increased risk of heart attack and stroke.
Men who allegedly experienced heart attacks, strokes, deep vein thrombosis, pulmonary embolism, and other serious cardiovascular complications related to the use of low testosterone therapy may be eligible to join this litigation. To learn more about filing a testosterone treatment lawsuit, please visit Bernstein Liebhard LLP's website. Free, no-obligation legal consultations can be obtained by calling 800-511-5092.
*http://www.fda.gov/Drugs/DrugSafety/ucm383904.htm, FDA, January 31, 2014
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The National Law Journal has recognized Bernstein Liebhard for twelve consecutive years as one of the top plaintiffs' firms in the country. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2015 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Sandy A. Liebhard, Esq.
Bernstein Liebhard LLP
info (at) consumerinjurylawyers (dot) com